z-logo
open-access-imgOpen Access
Carotid artery stenting versus carotid endarterectomy - a prospective randomised controlled single-centre trial with long-term follow-up (BACASS)
Author(s) -
Adrienne Hoffmann,
Stefan T. Engelter,
Christian Taschner,
Aminadav Mendelowitsch,
Andrea Merlo,
Philippe Lyrer,
Radue, W,
Eberhard Kirsch
Publication year - 2008
Publication title -
schweizer archiv für neurologie und psychiatrie
Language(s) - English
Resource type - Journals
eISSN - 1661-3686
pISSN - 0258-7661
DOI - 10.4414/sanp.2008.01926
Subject(s) - medicine , carotid endarterectomy , carotid arteries , endarterectomy , cardiology , carotid stenting , randomized controlled trial , surgery
Background and objective: Safety and effectiveness of carotid artery stenting (CAS) was compared with carotid endarterectomy (CEA) in a singlecentre prospective randomised controlled trial in symptomatic high-grade stenosis of the ICA. Material and methods: Twenty patients with symptomatic ICA stenosis 70% were prospectively randomised to either CAS or CEA. Primary outcome measures were periprocedural stroke, death or myocardial infarction. Secondary outcome measures were peri-interventional transient TIA, bleeding complications, cranial nerve paralysis, length of stay and ICA patency as well as stroke or death during long-term follow-up. Results: CAS patients had no peri-interventional complications. In the CEA group 1/10 had an ipsilateral non-disabling stroke after 16 days. During long-term follow-up (48.1 21.3 months with CAS and 43.5 19.5 months with CEA) neither strokes nor myocardial infarctions occurred in both groups. Length of stay was 3.5 1.8 days for CAS versus 7.3 3.3 days for CEA patients. CEA and CAS groups did not differ in other secondary outcome measures. Conclusion: CAS and CEA seem to be comparably safe in our setting. More importantly, data useful for a systematic meta-analysis are provided, which include long-term results.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom